STOCK TITAN

Canopy Growth Corp SEC Filings

CGC Nasdaq

Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Ever tried locating Canopy Growth’s biological asset valuations or U.S. THC exposure in a 300-page report? The company’s cannabis regulations, fair-value accounting and brand acquisitions make each disclosure dense. That’s why this page does more than list documents—it turns the tough parts of Canopy Growth SEC filings explained simply.

Every form—whether a Canopy Growth quarterly earnings report 10-Q filing or a sudden Canopy Growth 8-K material events explained—arrives here within seconds of hitting EDGAR. Stock Titan’s AI instantly produces plain-English summaries, highlights cash-flow turning points and links note references so you can move from headline to footnote without scrolling hundreds of pages. Need to monitor management moves? Our alert engine captures Canopy Growth Form 4 insider transactions real-time, flagging each Canopy Growth executive stock transactions Form 4 alongside price and option data.

Use the annual report to see cultivation capacity; the proxy to unpack Canopy Growth proxy statement executive compensation; or dive into segment margins with our Canopy Growth earnings report filing analysis. If you are tracking regulatory risk, the system groups risk-factor language across years so understanding Canopy Growth SEC documents with AI becomes a two-minute task. Investors, analysts and portfolio managers rely on these tools to answer questions like “What did management say about U.S. legalization timing?” or “Were there new goodwill impairments?”—all without manual page hunts. From the first Canopy Growth insider trading Form 4 transactions alert to a fully indexed Canopy Growth annual report 10-K simplified, every disclosure is refined for faster, smarter decision-making.

Rhea-AI Summary

Canopy Growth Corp (CGC) reported an insider update: a director filed a Form 3 initial statement of beneficial ownership. The filing states that no securities are beneficially owned as of the event date 10/10/2025.

The submission was filed by one reporting person and includes an Exhibit 24 Power of Attorney authorizing the signatory.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
insider
-
Rhea-AI Summary

Canopy Growth Corporation reported the final voting results from its 2025 Annual General and Special Meeting. Shareholders approved a share consolidation authorization, allowing the Board to set a consolidation ratio between 1-for-5 and 1-for-15 for common and exchangeable shares at any time prior to September 26, 2026. A total of 79,971,625 shares were represented out of 239,849,225 entitled to vote.

All five director nominees were elected. Shareholders approved the appointment of PKF O’Connor Davies, LLP as auditor for the fiscal year ending March 31, 2026. The advisory vote on executive compensation also passed.

Key tallies: the share consolidation resolution received 62,742,664 votes for, 16,557,315 against, and 671,647 abstentions; the auditor appointment received 75,518,055 votes for and 4,453,570 withheld.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
current report
-
Rhea-AI Summary

David Angelo Lazzarato, a director of Canopy Growth Corp (CGC), reported a sale of 15,677 common shares on 09/29/2025 at a price of $1.58 per share. After the sale, he beneficially owned 103,387 shares directly. The filing states the shares disposed were originally granted as restricted stock units on June 3, 2025 and were sold to satisfy tax obligations arising from RSU vesting. The Form 4 was signed on behalf of Mr. Lazzarato by an attorney-in-fact on 09/30/2025. The filing is a routine Section 16 disclosure of an insider transaction related to tax withholding at vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Canopy Growth director Margaret Shan Atkins reported a disposition of common shares tied to vested restricted stock units. On 09/29/2025 the reporting person disposed of 2,216 common shares at $1.58 per share to satisfy tax obligations arising from RSUs granted on 08/12/2025. After the reported transaction the reporting person beneficially owned 43,464 common shares, held directly. The Form 4 indicates the sale is associated with tax withholding on vested equity rather than a separate open-market trading decision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Theresa Yanofsky, a director of Canopy Growth Corp (CGC), reported a sale of common shares tied to vested restricted stock units. The Form 4 shows a transaction dated 09/29/2025 in which 10,408 common shares were disposed at a price of $1.58 per share, leaving the reporting person with 73,952 shares beneficially owned. The filing explains these shares were originally granted as restricted stock units on June 3, 2025, and the disposition is associated with the reporting person’s tax obligations arising from RSU vesting. The Form 4 was signed by an attorney-in-fact on 09/30/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Canopy Growth Corp (CGC) director Willy Kruh reported the sale of 10,451 common shares on 09/29/2025 at $1.58 per share, leaving him with 62,939 shares beneficially owned. The Form 4 states the shares sold were previously granted as restricted stock units on June 3, 2025, and the sale was made to satisfy tax obligations arising from vesting. The filing is signed by an attorney-in-fact on behalf of the reporting person on 09/30/2025. The report is a single-person Form 4 disclosure and identifies the reporting person as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Canopy Growth Corp director and Chief Executive Officer Luc Mongeau (reporting person) acquired 27,469 common shares on 09/22/2025 at a price of CA$1.82 per share, as reported on Form 4. Following the transaction, Mongeau beneficially owned 812,368 common shares. The Form 4 was signed by an attorney-in-fact on behalf of Mongeau on 09/23/2025. The filing notes that the price is expressed in Canadian dollars. No derivative transactions or additional details were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Stewart Thomas Carlton, serving as Chief Financial Officer and Chief Accounting Officer of Canopy Growth Corp (CGC), reported equity awards granted on 09/17/2025. He received 178,462 restricted stock units (RSUs) that vest in three equal annual installments, and was granted 222,280 stock options$1.40 that vest in three equal annual installments and expire on 09/17/2031. After the reported transactions, the filing shows 246,665 common shares beneficially owned by the reporting person. The form reflects standard compensation awards for executive retention and alignment with shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
insider
-
Rhea-AI Summary

Canopy Growth Corp filed an Form 8-K reporting an employment agreement effective September 17, 2025 between Canopy Growth USA, LLC and Thomas Stewart. The filing references standard 8-K items including departures/elections or appointments of officers or directors, Regulation FD disclosure, and financial statements and exhibits. The exhibits listed include the Employment Agreement, a Press Release dated September 17, 2025, and an embedded Inline XBRL cover page data file. The document is signed by Christelle Gedeon, Chief Legal Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.21%
Tags
current report
Rhea-AI Summary

Canopy Growth Corporation filed an Form 8-K reporting Regulation FD disclosure and other events. The filing lists an Equity Distribution Agreement dated August 29, 2025 with BMO Capital Markets Corp. and BMO Nesbitt Burns Inc., legal opinion and consent from Cassels Brock & Blackwell LLP, and a press release dated August 29, 2025. The company also references an Interactive Data File (Inline XBRL) and notes that one non-material exhibit was omitted under Item 601(a)(5) of Regulation S-K, with supplemental copies available on request to the SEC.

The document is primarily an exhibits and disclosure notice; it does not include financial tables, earnings figures, or details of the equity distribution terms within the text provided here.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.22%
Tags
current report

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.46 as of October 15, 2025.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 424.3M.
Canopy Growth Corp

Nasdaq:CGC

CGC Rankings

CGC Stock Data

424.31M
311.58M
0.07%
7.26%
6.76%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS